Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of PEG-400 Artificial Tear vs Systane in Dry Eye
NCT00622037Phase 4Completed
- Sponsor
- BP Consulting
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of polyethylene glycol 400 in dry eye syndrome (DED) (2 arms), sponsored by BP Consulting. Primary endpoint: Dry Eye Signs at 4 months. Started Feb 2008; status: completed.
02
Drugs
polyethylene glycol 400
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00622037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622037.